nVerses Capital’s Hologic HOLX Stock Holding History

nVerses Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,100	Closed	-$601K	–	1177
2024 Q2	$601K	Buy	+8,100	New	+$607K	0.36%	75

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

nVerses Capital's HOLX Position: Q3 2024 in Review

nVerses Capital sold out of Hologic (HOLX) in Q3 2024, closing a stake of 8,100 shares — an estimated $601K sold.

nVerses Capital first reported a position in HOLX in Q2 2024 and held it in 1 quarter. The position peaked at $601K in Q2 2024. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

nVerses Capital reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 8,100 Hologic shares in Q3 2024, an estimated $601K.
nVerses Capital first reported a position in Hologic in Q2 2024 and held it in 1 quarter.
nVerses Capital's Hologic position peaked at $601K in Q2 2024.
727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.